BeiGene Presents Updated Head to Head Results from Phase 3

 PDF   10   06/2020

BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Patients with Waldenström’s Macroglobulinemia at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!
Service